Table 3.

Significant predictors of routine recommendation of primary human papillomavirus (HPV) testing for average-risk, asymptomatic women ≥30 years old among US providers who perform cervical cancer screening, multivariate logistic regression, DocStyles survey, 2015 (N = 843).

Significant predictors	Predictive category	Adj. OR	95% CI	Reference category
Specialty	Family practitioner	0.44	0.30–0.63	Internist
	Obstetrician-gynecologist	0.31	0.18–0.52
Gender	Male	1.56	1.11–2.21	Female
Race	Asian	1.95	1.36–2.81	White
	Black	0.46	0.12–1.80
	Other	0.96	0.54–1.70
Hispanic ethnicity	Yes	2.38	1.09–5.20	No
Factors influencing cervical cancer screening practices	Influenced by patient HPV vaccination status	3.96	2.82–5.57	Not influenced by patient HPV vaccination status
	Influenced by practice guidelines	0.45	0.27–0.74	Not influenced by practice guidelines

Note: Table includes variables in the multivariate model with one or more significant categories. The forward, stepwise multivariate model included variables significantly associated with routine recommendation of primary HPV testing for average-risk, asymptomatic women in bivariate analyses (Table 2): specialty, gender, race, ethnicity, number of cervical cancer screenings performed during a typical month, and three influences on cervical cancer screening practices—practice guidelines, patient preference, and patient HPV vaccination status. Analyses were limited to physicians who reported that cervical cancer screening was within the scope of their practice and performed cervical cancer screening during a typical month.